Isabella Bon

1.1k total citations
74 papers, 770 citations indexed

About

Isabella Bon is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Isabella Bon has authored 74 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 51 papers in Virology and 23 papers in Emergency Medicine. Recurrent topics in Isabella Bon's work include HIV Research and Treatment (51 papers), HIV/AIDS drug development and treatment (45 papers) and HIV/AIDS Research and Interventions (29 papers). Isabella Bon is often cited by papers focused on HIV Research and Treatment (51 papers), HIV/AIDS drug development and treatment (45 papers) and HIV/AIDS Research and Interventions (29 papers). Isabella Bon collaborates with scholars based in Italy, United Kingdom and Switzerland. Isabella Bon's co-authors include Maria Carla Re, Davide Gibellini, Marco Borderi, Leonardo Calza, Pierluigi Viale, Vincenzo Colangeli, Francesca Vitone, Federica Alessandrini, Anna Miserocchi and Cristina Ponti and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Isabella Bon

71 papers receiving 757 citations

Peers

Isabella Bon
Isabella Bon
Citations per year, relative to Isabella Bon Isabella Bon (= 1×) peers Carmela Pinnetti

Countries citing papers authored by Isabella Bon

Since Specialization
Citations

This map shows the geographic impact of Isabella Bon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabella Bon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabella Bon more than expected).

Fields of papers citing papers by Isabella Bon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabella Bon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabella Bon. The network helps show where Isabella Bon may publish in the future.

Co-authorship network of co-authors of Isabella Bon

This figure shows the co-authorship network connecting the top 25 collaborators of Isabella Bon. A scholar is included among the top collaborators of Isabella Bon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabella Bon. Isabella Bon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Calza, Leonardo, et al.. (2023). Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years. AIDS Research and Human Retroviruses. 40(2). 73–79. 7 indexed citations
3.
Chiereghin, Angela, Rocco Maurizio Zagari, Silvia Galli, et al.. (2021). Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19. Frontiers in Public Health. 8. 620222–620222. 20 indexed citations
4.
Calza, Leonardo, Marco Borderi, Vincenzo Colangeli, et al.. (2020). Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir. AIDS Research and Human Retroviruses. 37(3). 204–206. 6 indexed citations
5.
Calza, Leonardo, et al.. (2020). Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine. AIDS Research and Human Retroviruses. 37(1). 11–15. 1 indexed citations
6.
Bon, Isabella, Annelies Verbon, Casper Rokx, et al.. (2019). Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1. Journal of Virological Methods. 276. 113778–113778. 16 indexed citations
7.
Falasca, Francesca, Daniele Di Carlo, Corrado De Vito, et al.. (2017). Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infectious Diseases. 17(1). 581–581. 31 indexed citations
8.
Bon, Isabella, David Lembo, Valeria Cagno, et al.. (2017). M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures. Scientific Reports. 7(1). 41018–41018. 8 indexed citations
9.
Calza, Leonardo, Vincenzo Colangeli, Marco Borderi, et al.. (2017). Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients. AIDS. 31(5). 681–688. 12 indexed citations
10.
Magnani, G., Isabella Bon, Serena Longo, et al.. (2016). HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): a three year study.. PubMed. 39(4). 241–246. 3 indexed citations
11.
Calza, Leonardo, Vincenzo Colangeli, Isabella Bon, et al.. (2016). Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy. AIDS Research and Human Retroviruses. 33(2). 126–132. 15 indexed citations
12.
Montagna, Claudia, Elisa De Crignis, Isabella Bon, et al.. (2014). V3 Net Charge: Additional Tool in HIV-1 Tropism Prediction. AIDS Research and Human Retroviruses. 30(12). 1203–1212. 5 indexed citations
13.
Gibellini, Davide, Marco Borderi, Anna Miserocchi, et al.. (2013). HIV-related mechanisms in atherosclerosis and cardiovascular diseases. Journal of Cardiovascular Medicine. 14(11). 780–790. 27 indexed citations
14.
Bon, Isabella, Massimo Ciccozzi, Alessia Lai, et al.. (2010). HIV-1 subtype C transmission network: The phylogenetic reconstruction strongly supports the epidemiological data. Journal of Clinical Virology. 48(3). 212–214. 11 indexed citations
15.
Re, Maria Carla, et al.. (2010). Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy. International Journal of Infectious Diseases. 14(11). e1008–e1012. 14 indexed citations
16.
Re, Maria Carla, et al.. (2006). Meaning of DNA detection during the follow-up of HIV-1 infected patients: a brief review.. PubMed. 29(2). 81–8. 22 indexed citations
17.
Re, Maria Carla, Isabella Bon, Paola Monari, et al.. (2003). Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleoside and non nucleoside inhibitors. International Journal of Antimicrobial Agents. 22(4). 388–394. 8 indexed citations
18.
Re, Maria Carla, Paola Monari, Isabella Bon, et al.. (2002). Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenz. International Journal of Antimicrobial Agents. 20(3). 223–226. 7 indexed citations
19.
Re, Maria Carla, Marco Borderi, Paola Monari, et al.. (2001). Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a cohort of Italian HIV-1 seropositive patients extensively treated with antiretroviral drugs. International Journal of Antimicrobial Agents. 18(6). 519–523. 7 indexed citations
20.
Re, Maria Carla, Paola Monari, Isabella Bon, et al.. (2001). Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients. BMC Microbiology. 1(1). 30–30. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026